LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro.
about
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
LIGHT/TNFSF14 is increased in ...... al cell inflammation in vitro.
@en
LIGHT/TNFSF14 is increased in ...... al cell inflammation in vitro.
@nl
type
label
LIGHT/TNFSF14 is increased in ...... al cell inflammation in vitro.
@en
LIGHT/TNFSF14 is increased in ...... al cell inflammation in vitro.
@nl
prefLabel
LIGHT/TNFSF14 is increased in ...... al cell inflammation in vitro.
@en
LIGHT/TNFSF14 is increased in ...... al cell inflammation in vitro.
@nl
P2093
P2860
P50
P1433
P1476
LIGHT/TNFSF14 is increased in ...... al cell inflammation in vitro.
@en
P2093
Afaf Sahraoui
Annika E Michelsen
Benedicte Stavik
Cecilie Wium
Francesca Santilli
Giovanni Davi
Gloria Formoso
Hanne L Gulseth
Hanne Scholz
Ida Gregersen
P2860
P2888
P304
P356
10.1007/S00125-016-4036-Y
P577
2016-07-15T00:00:00Z